Clicky

Connect Biopharma Holdings Limited(CNTB) News

Date Title
Jul 22 Connect Biopharma Appoints Industry Veteran Jim Schoeneck to its Board of Directors
Jul 21 Connect Biopharma Announces Plans to Terminate its American Depositary Receipt Program and Directly List its Ordinary Shares on Nasdaq
Jul 18 Connect Biopharma to Participate in the BTIG Virtual Biotechnology Conference
Jul 17 Connect Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
Jul 16 3 Penny Stocks With Market Caps Over $30M To Consider
Jul 9 Connect Biopharma’s Exclusive Licensee in China, Simcere Pharmaceutical, Announced Submission of its New Drug Application for Rademikibart for the Treatment of Atopic Dermatitis in China
Jun 17 3 Promising Penny Stocks With Market Caps Over $10M
Jun 13 Connect Biopharma Presents Data Supporting Rademikibart at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress
May 28 Connect Biopharma to Present at Two Upcoming Investor Conferences in June
Apr 24 Connect Biopharma Announces Multiple Presentations at the American Thoracic Society (ATS) 2025 International Conference
Apr 11 Bullfrog AI and Connect Biopharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Apr 7 Talkspace And 2 Other Promising Penny Stocks
Mar 3 Connect Biopharma to Present at Two Upcoming Investor Conferences
Feb 28 Connect Biopharma Holdings And Two Other Promising Penny Stocks To Watch
Dec 31 3 US Penny Stocks With Market Caps Under $400M To Consider
Sep 10 Connect Biopharma to Participate in the Cantor Fitzgerald Global Healthcare Conference 2024
Sep 5 Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update
May 7 Connect Biopharma to Present a Late-Breaking Abstract at the American Thoracic Society (ATS) 2024 International Conference on the Positive Results from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma
May 2 Stonegate Healthcare Partners Updates Report on Transformative Therapies for Pruritus Management
Apr 16 Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update